ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VREX Varex Imaging Corporation

14.74
0.29 (2.01%)
Last Updated: 14:56:43
Delayed by 15 minutes
Share Name Share Symbol Market Type
Varex Imaging Corporation NASDAQ:VREX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.29 2.01% 14.74 14.76 14.82 14.82 14.50 14.56 18,050 14:56:43

Current Report Filing (8-k)

15/07/2019 11:11am

Edgar (US Regulatory)




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  ____________________________________________________
FORM 8-K
  ____________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 11, 2019
     ____________________________________________________
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
  ____________________________________________________
Delaware
(State or Other Jurisdiction of Incorporation)
 
001-37860
 
81-3434516
(Commission File Number)
 
(IRS Employer
Identification No.)

1678 S. Pioneer Road, Salt Lake City, Utah
 
84104
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000
Not Applicable
(Former name or former address, if changed since last report)
 ____________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
VREX
The Nasdaq Global Select Market

  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 2.05
Costs Associated with Exit or Disposal Activities

On July 11, 2019, after receiving approval of the Board of Directors of Varex Imaging Corporation (the “Company”), management committed to closing the Company’s Santa Clara facility.  The closure of the Company's Santa Clara facility is being taken in connection with the ongoing integration of the imaging business acquired from PerkinElmer, Inc. in May 2017 and we expect operations at the Santa Clara facility to cease by the end of December 2020. Due to the closure of the Santa Clara facility, the Company anticipates the elimination of approximately 110 positions at the Santa Clara facility. The Company anticipates that all activities related to the closure of the Santa Clara facility will be completed by the end of March 2021.

The total amount of restructuring charges is expected to be in the range of $20 to $24 million, including approximately $6 million of accelerated depreciation, $6 to $7 million for the impairment of assets, $5 to $7 million for employee and severance related costs and $3 to $4 million for the remaining lease obligations.  The Company expects that approximately $8 to $11 million of these restructuring charges will result in future cash expenditures. The Company expects that the closure of the Santa Clara facility will deliver approximately $12 to $16 million in annual cost savings.

Item 2.06
Material Impairments

The information set forth above in Item 2.05 is incorporated by reference into this Item 2.06.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
 
VAREX IMAGING CORPORATION
 
 
 
Dated: July 12, 2019
By:
/s/ Kimberley E. Honeysett
 
 
Kimberley E. Honeysett
 
 
Senior Vice President, General Counsel and Corporate Secretary




1 Year Varex Imaging Chart

1 Year Varex Imaging Chart

1 Month Varex Imaging Chart

1 Month Varex Imaging Chart

Your Recent History

Delayed Upgrade Clock